Thanh Nha Thai, MD
LightNews LightNews
thaithanhnha.bsky.social
Thanh Nha Thai, MD
@thaithanhnha.bsky.social
360 followers 560 following 220 posts
Cardiologist 🫀
#cardiosky
Posts Replies Media Videos
Reposted by Thanh Nha Thai, MD
wsj.com
Novo Nordisk shares fell sharply after it said a pill with the key ingredient in Ozempic and Wegovy didn’t slow Alzheimer’s disease in two late-stage clinical trials.
Novo Nordisk Shares Slump After Ozempic Pill Fails in Alzheimer’s Trials
Oral semaglutide—the ingredient in obesity and diabetes drugs Ozempic and Wegovy—didn’t slow Alzheimer’s disease in two late-stage clinical trials.
on.wsj.com
November 24, 2025 at 12:42 PM
thaithanhnha.bsky.social
New insights into the management of fulminant myocarditis

academic.oup.com/eurheartj/ad....

@escardio.bsky.social
#CardioSky #EHJ
November 24, 2025 at 12:40 PM
thaithanhnha.bsky.social
Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers: Multidatabase Target Trial Emulation Studies.

www.ahajournals.org/doi/10.1161/...

@ahascience.bsky.social @ahajournals.bsky.social
#CardioSky #Hypertension
November 22, 2025 at 3:53 AM
thaithanhnha.bsky.social
Evidence-Based Practices in the Cardiac Catheterization Laboratory: Invasive Epicardial Coronary Physiologic Assessment: A Scientific Statement From the American Heart Association.

www.ahajournals.org/doi/10.1161/...

@ahascience.bsky.social @ahajournals.bsky.social
#CardioSky #Circulation
Factors affecting concordance between fractional flow reserve and nonhyperemic pressure ratio. CFR indicates coronary flow reserve; FFR, fractional flow reserve; and NHPR, nonhyperemic pressure ratio. Pyramid of diagnostic accuracy. FFR indicates fractional flow reserve; and NHPR, nonhyperemic pressure ratio.
November 20, 2025 at 1:33 PM
thaithanhnha.bsky.social
Long QT Syndrome.

www.nejm.org/doi/full/10....

@nejm.org
#CardioSky
November 20, 2025 at 1:27 PM
Reposted by Thanh Nha Thai, MD
thaithanhnha.bsky.social
Coronary Artery Revascularization in the Older Adult Population: A Scientific Statement From the American Heart Association.

www.ahajournals.org/doi/10.1161/...

@ahascience.bsky.social @ahajournals.bsky.social
#CardioSky
The 4 pillars of risk in older adults presenting for coronary revascularization procedures Choosing among coronary revascularization options
November 19, 2025 at 1:42 PM
Reposted by Thanh Nha Thai, MD
thaithanhnha.bsky.social
ESICM guidelines on circulatory shock and hemodynamic monitoring 2025.

@esicm.bsky.social @intenscaremed.bsky.social
#CardioSky

Full text: rdcu.be/eQyqN
November 18, 2025 at 1:29 PM
Reposted by Thanh Nha Thai, MD
ddiamond.bsky.social
CDC has overhauled its website to assert that “the claim ‘vaccines do not cause autism’ is not an evidence-based claim”
Autism and Vaccines QUESTIONS AND CONCERNS PAGE 2 OF 9 | ALL PAGES J For Everyone NOV. 19, 2025 KEY POINTS • The claim "vaccines do not cause autism" is not an evidence-based claim because studies have not ruled out the possibility that infant vaccines cause autism. • Studies supporting a link have been ignored by health authorities. HHS Research on Plausible Biologic Mechanisms between Vaccines and Autism HHS will evaluate plausible biologic mechanisms between early childhood vaccinations and autism. Mechanisms for further investigation include the impacts of aluminum adjuvants, risks for certain children with mitochondrial disorders, harms of neuroinflammation, and more. * The header "Vaccines do not cause autism" has not been removed due to an agreement with the chair of the U.S. Senate Health, Education, Labor, and Pensions Committee that it would remain on the CDC website.
November 20, 2025 at 2:26 AM
Reposted by Thanh Nha Thai, MD
ndt-era.bsky.social
Cardio-renoprotective effects of SGLT2 inhibitors—the role of anaemia correction

doi.org/10.1093/ndt/...
Cardio-renoprotective effects of SGLT2 inhibitors—the role of anaemia correction
Sodium/glucose co-transporter 2 inhibitors (SGLT2i) slow the progression of chronic kidney disease (CKD) and heart failure without the risk of concomitant
doi.org
November 20, 2025 at 10:00 AM
thaithanhnha.bsky.social
Coronary Artery Revascularization in the Older Adult Population: A Scientific Statement From the American Heart Association.

www.ahajournals.org/doi/10.1161/...

@ahascience.bsky.social @ahajournals.bsky.social
#CardioSky
The 4 pillars of risk in older adults presenting for coronary revascularization procedures Choosing among coronary revascularization options
November 19, 2025 at 1:42 PM
thaithanhnha.bsky.social
ESICM guidelines on circulatory shock and hemodynamic monitoring 2025.

@esicm.bsky.social @intenscaremed.bsky.social
#CardioSky

Full text: rdcu.be/eQyqN
November 18, 2025 at 1:29 PM
Reposted by Thanh Nha Thai, MD
thaithanhnha.bsky.social
Coming soon! Textbook of Interventional Cardiology 9th Edition.

@erictopol.bsky.social @elsevierconnect.bsky.social
#CardioSky
November 16, 2025 at 7:26 AM
thaithanhnha.bsky.social
Coming soon! Textbook of Interventional Cardiology 9th Edition.

@erictopol.bsky.social @elsevierconnect.bsky.social
#CardioSky
November 16, 2025 at 7:26 AM
Reposted by Thanh Nha Thai, MD
jaccjournals.bsky.social
Visceral fat is the hidden driver linking CKD and HFpEF. This Special Communication reframes adiposity as a pathogenic organ fueling renal and cardiac decline. #HFpEF #CKD

More in the newest issue of #JACC: https://bit.ly/43ioRpq

#CardioSky
November 15, 2025 at 9:10 PM
Reposted by Thanh Nha Thai, MD
hmkyale.bsky.social
After two years and thousands of manuscripts, I’ve learned that the real work of an editor isn’t gatekeeping — it’s partnership.

My latest JACC Editor’s Page: The Partnership

🔗 www.jacc.org/doi/10.1016/...

#MedTwitter #AcademicMedicine #Cardiology
November 11, 2025 at 7:50 PM
Reposted by Thanh Nha Thai, MD
criticalcarereviews.com
Just 4 weeks to CCR Down Under 2025!

Join us to hear the results of 8 major critical care trials - in person or virtually

➡️ ImmunoSep
➡️ iRehab
➡️ CLIP II
➡️ ACTiVE
➡️ ARISE AFRICA
➡️ RSI
➡️ VITaCCA
➡️ ECMO REHAB

https://criticalcarereviews.com/meetings/ccr-down-under-2025
November 11, 2025 at 10:10 PM
thaithanhnha.bsky.social
Pragmatic Approaches to the Evaluation and Monitoring of Artificial Intelligence in Health Care: A Science Advisory From the American Heart Association.

www.ahajournals.org/doi/10.1161/...

@ahascience.bsky.social @ahajournals.bsky.social
#CardioSky #AI
November 11, 2025 at 12:28 PM
Reposted by Thanh Nha Thai, MD
jama.com
The most common chronic liver disease worldwide, metabolic dysfunction–associated steatotic liver disease (MASLD) affects approximately 30% to 40% of the general adult population.

This Review summarizes the diagnosis, treatment, and prognosis of MASLD. ja.ma/3XiORgN
Figure outlines MASLD progression from healthy liver to cirrhosis/hepatic decompensation. Factors promoting MASLD include diet, insulin resistance; protective factors: physical exercise, socioeconomic status. Progression rates are shown. Text: JAMA, Published online November 10, 2025.
November 10, 2025 at 4:30 PM
Reposted by Thanh Nha Thai, MD
thaithanhnha.bsky.social
State of the Art: Evaluation and Medical Management of Nonobstructive Coronary Artery Disease in Patients With Chest Pain: A Scientific Statement From the American Heart Association

www.ahajournals.org/doi/10.1161/...

@ahascience.bsky.social @ahajournals.bsky.social
#CardioSky
November 10, 2025 at 2:18 PM
thaithanhnha.bsky.social
State of the Art: Evaluation and Medical Management of Nonobstructive Coronary Artery Disease in Patients With Chest Pain: A Scientific Statement From the American Heart Association

www.ahajournals.org/doi/10.1161/...

@ahascience.bsky.social @ahajournals.bsky.social
#CardioSky
November 10, 2025 at 2:18 PM
Reposted by Thanh Nha Thai, MD
erictopol.bsky.social
Get this: Coffee suppressed atrial fibrillation!
Unexpected results for recurrence from a randomized trial in participants after cardioversion from AF
#AHA25 @jama.com
jamanetwork.com/journals/jam...
November 9, 2025 at 2:51 PM
Reposted by Thanh Nha Thai, MD
nejm.org
In a meta-analysis of 17,801 patients with myocardial infarction and preserved LVEF (≥50%), beta-blockers did not reduce death, MI, or heart failure over a median 3.6 years of follow-up. Full results: nej.md/43U5Ppo

#AHA25
Kaplan–Meier curves of the cumulative incidence of death from any cause, myocardial infarction, or heart failure (the composite primary end point).
November 9, 2025 at 4:14 PM
Reposted by Thanh Nha Thai, MD
nejm.org
Among patients with atherosclerosis or diabetes but no previous myocardial infarction or stroke, evolocumab led to a lower risk of major adverse cardiovascular events than placebo. Full VESALIUS-CV trial results: nej.md/4oWrIN6

#AHA25
American Heart Association Scientific Sessions 2025 Original Article | Nov 8, 2025 | NEJM.org Evolocumab in Patients without a Previous Myocardial Infarction or Stroke Figure 1A. 3-Point MACE.   The NEJM identity sits at the bottom.
November 8, 2025 at 3:36 PM
Reposted by Thanh Nha Thai, MD
thaithanhnha.bsky.social
Coming soon! Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 13th edition .

@elsevierconnect.bsky.social
#CardioSKy
November 5, 2025 at 12:54 PM
thaithanhnha.bsky.social
Coming soon! Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 13th edition .

@elsevierconnect.bsky.social
#CardioSKy
November 5, 2025 at 12:54 PM